SURGICAL INSTITUTE OF READING — History
CCN 390316 | 3-year financial timeline | COVID resilience: 58/100
🛡️ Public data only — no PHI permitted on this instance.
$59M
Latest Revenue (FY2022)
+9.9%
Revenue CAGR (3yr)
28.1%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $48M | $55M | $59M | +5.5% | +9.9% |
| Operating Expenses | $33M | $38M | $42M | +12.0% | +12.6% |
| Operating Margin | 31.5% | 32.3% | 28.1% | -12.9% | -5.6% |
| Net Income | $15M | $18M | $16M | -8.1% | +3.7% |
| Licensed Beds | 15 | 15 | 15 | +0.0% | +0.0% |
| Total Patient Days | 933 | 776 | 650 | -16.2% | -16.5% |
| Medicare Day % | 45% | 51% | 52% | +0.5% | +6.9% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 58/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +20.7% ($48M → $59M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+9.9%
This Hospital
+7.6%
State Avg
Latest Margin
28.1%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $64M | 26.4% |
| FY2024 (proj) | $69M | 24.7% |
| FY2025 (proj) | $74M | 23.0% |